` GSS (Genetic Signatures Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

GSS
vs
S
S&P/ASX 300

Over the past 12 months, GSS has underperformed S&P/ASX 300, delivering a return of -63% compared to the S&P/ASX 300's +5% growth.

Stocks Performance
GSS vs S&P/ASX 300

Loading
GSS
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
GSS vs S&P/ASX 300

Performance Gap Between GSS and AXKO
HIDDEN
Show

Performance By Year
GSS vs S&P/ASX 300

Loading
GSS
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Genetic Signatures Ltd vs Peers

S&P/ASX 300
GSS
0KHE
TMO
DHR
LONN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Genetic Signatures Ltd
Glance View

Genetic Signatures Ltd. engages in the research and commercialization of identifying individual genetic signatures to identify diseases and disabilities. The company is headquartered in Sydney, New South Wales. The company went IPO on 2015-03-31. The firm is engaged in research and commercialization of identifying individual genetic signatures to aid in the diagnosis of infectious diseases and the sale of associated products into the diagnostic and research marketplaces. The firm is focused on the development and commercialization of its platform technology, 3Base. The Company’s 3Base platform technology provides hospital and pathology laboratories the ability to screen for an array of infectious pathogens, with a degree of specificity, in a rapid throughput (time-to-result) environment. The company also manufactures a Polymerase Chain Reaction (PCR) based products for the detection of infectious diseases under the EasyScreen brand. The Company’s EasyScreen sample processing kits are used to perform 3Base conversion and nucleic acid extraction and purification.

GSS Intrinsic Value
HIDDEN
Show
Back to Top